Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

被引：4
|
作者：
Fava, Carmen [1 ]
Cambrin, Giovanna Rege [1 ]
Ferrero, Dario [2 ]
Ulisciani, Stefano [1 ]
Serra, Anna [1 ]
机构：
[1] San Luigi Hosp, Dept Internal Med Hematol, Orbassano, Italy
[2] Molinette Mauriziano Hosp, Turin, Italy
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷 / 06期
关键词：
D O I：
10.3816/CLM.2009.n.102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E41 / E41
页数：1
相关论文
共 50 条
  • [1] COEXISTENCE OF A JAK2 MUTATED CLONE MAY CAUSE HEMATOLOGIC RESISTANCE (HRES) TO TIROSYN-KINASE INHIBITORS (TKI) IN CHRONIC MYELOID LEUKEMIA (CML)
    Fava, C.
    Rege-Cambrin, G.
    Ferrero, D.
    Ulisciani, S.
    Serra, A.
    Giugliano, E.
    Fava, M.
    Gottardi, E.
    Giaretto, L.
    Saglio, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 575 - 575
  • [2] Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Lewandowski, K.
    Gniot, M.
    Wojtaszewska, M.
    Kandula, Z.
    Becht, R.
    Paczkowska, E.
    Medras, E.
    Wasilewska, E.
    Iwola, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (03) : 366 - 371
  • [3] Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Lion, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S3 - S3
  • [4] Mutations of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Kihel, I.
    Nachi, M.
    Bekadja, M. A.
    CLINICA CHIMICA ACTA, 2022, 530 : S334 - S335
  • [5] Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Baccarani, Michele
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Rosti, Gianantonio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 397 - 406
  • [6] Tyrosine kinase inhibitors in chronic myeloid leukemia
    Sawyers, CL
    Druker, B
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (02): : 63 - 69
  • [7] Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia
    Sun, Jingnan
    Hu, Ruiping
    Han, Mengyuan
    Tan, Yehui
    Xie, Mengqing
    Gao, Sujun
    Hu, Ji-Fan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (01): : 175 - 181
  • [8] Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
    Ganguly, Bani Bandana
    Kadam, Nitin N.
    NUCLEUS-INDIA, 2019, 62 (02): : 155 - 164
  • [9] Dual tyrosine kinase inhibitors in chronic myeloid leukemia
    Martinelli, G
    Soverini, S
    Rosti, G
    Baccarani, M
    LEUKEMIA, 2005, 19 (11) : 1872 - 1879
  • [10] New tyrosine kinase inhibitors in chronic myeloid leukemia
    Martinelli, Giovanni
    Soverini, Simona
    Rosti, Gianantonio
    Cilloni, Daniela
    Baccarani, Michele
    HAEMATOLOGICA, 2005, 90 (04) : 534 - 541
12345